ArticleScientific reports2025
The evolution of vestibular function and health-related quality of life in bilateral vestibulopathy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07709143 (The Clinical Trial Protocol), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Clinical Trial Protocol: MRI Performance and Risk Factors of Bilateral Vestibular Hypofunction: A Multi-center Cross-sectional Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Little is known about the evolution of vestibular dysfunction and health-related quality of life in bilateral vestibulopathy patients over time. Furthermore, it is unknown whether etiology influences the evolution. A retrospective study was performed investigating the vestibular function at two different time points during a median follow-up time of 24 months in 97 bilateral vestibulopathy patients. Additionally, to evaluate the quality of life and symptoms, validated questionnaires were analyzed. The sum of the caloric testing on the right side and the gain of the rotatory chair torsion swing test significantly decreased over time (p = 0.020 and p = 0.017, respectively). The left-sided caloric tests remained stable, but the median was already 0°/sec at baseline testing. On the contrary, vHIT gain significantly improved on both sides during follow-up (right: p = 0.003, left: p = 0.000). However, the median differences were not clinically relevant. Only two patients (2%) who improved on caloric testing, failed to reach the criteria for bilateral vestibulopathy at follow-up. Both patients had idiopathic bilateral vestibulopathy. At baseline, these patients did already not comply with the criteria for bilateral vestibulopathy based on the vHIT and/or torsion swing test. There was no significant change in the total DHI, EQ-5D-5 L VAS, or HADS scores. The EQ-5D-5 L index significantly increased (p = 0.034). No significant relationship could be determined between etiology and the evolution of vestibular function, quality of life, and symptoms. In conclusion, in the majority of bilateral vestibulopathy patients, vestibular function, health-related quality of life and symptoms did not show a clinically relevant improvement over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.